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Abstract
Background: Cytokines play important roles in antiviral action. We examined whether
polymorphisms of IFN-γ,TNF-α and IL-10 affect the susceptibility to and outcome of severe acute
respiratory syndrome (SARS).
Methods: A case-control study was carried out in 476 Chinese SARS patients and 449 healthy
controls. We tested the polymorphisms of IFN-γ,TNF-α and IL-10 for their associations with SARS.
Results: IFN-γ +874A allele was associated with susceptibility to SARS in a dose-dependent manner
(P < 0.001). Individuals with IFN-γ +874 AA and AT genotype had a 5.19-fold (95% Confidence
Interval [CI], 2.78-9.68) and 2.57-fold (95% CI, 1.35-4.88) increased risk of developing SARS
respectively. The polymorphisms of IL-10 and TNF-α were not associated with SARS susceptibility.
Conclusion: IFN-γ +874A allele was shown to be a risk factor in SARS susceptibility.
Background
Severe acute respiratory syndrome (SARS) is an infectious
disease caused by SARS coronavirus [1] with >8000 cases
and 774 deaths reported in 2003 [2]. Much progress has
been made in understanding SARS coronavirus but the
pathogenesis is still unclear [3]. It was reported that old
age, diabetes mellitus and heart disease were risk factors
for adverse prognosis of SARS [4-6], however, little is
known about the contribution of genetic factors. We have
demonstrated that genetic haplotypes associated with low
serum mannose-binding lectin (MBL) were associated
with SARS [7] and our findings were recently replicated
[8]. Recently, homozygotes for CLEC4M tandem repeats
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Chinese [9].
Cytokines are known to be important in antiviral action.
Interferon (IFN)-γ from T and natural killer (NK) cells is
important in driving the T helper cell type 1 (Th1)
responses. It also activates monocytes and macrophages,
which in turn take part in antiviral responses by produc-
ing free radicals and pro-inflammatory cytokines like
tumor necrosis factor (TNF)-α. [10]. TNF-α then regulates
expression of neutrophil-endothelial cell adhesion mole-
cules and chemokines, which recruit leukocytes to the site
of infection [11-13]. Thus, IFN-γand TNF-α play impor-
tant role in antiviral response and inflammation.
Interleukin 10 (IL-10) is an antiinflammatory cytokine
that inhibits the activation and effector function of Th1
cells, monocytes, and macrophages [14]. IL-10 appears to
limit and ultimately terminate inflammatory responses by
blocking the expression of a number of pro-inflammatory
cytokines and chemokines [15]. In animal model, IL10
counteracts the inflammatory response by inhibiting TNF-
α production and neutrophil activation, and leads to a
reduction of the lung tissue injury [16]. Thus, IL-10 plays
an important role in regulating many immune and
inflammatory processes. Various studies showed that a
high IL-10 level would result in suppression of innate host
defense and lead to increasing susceptibility of the host to
various microbes and death [17-19].
In this study, we hypothesized that the polymorphisms of
the cytokine genes, i.e. IFN-γ +874A/T, TNF-α -308G/A,
IL-10 -1082G/A and -592A/C, might be associated with
SARS. These genes were chosen based on their functions
in antiviral response and inflammation regulation that
may be involved in SARS pathogenesis and their polymor-
phisms based on their potential regulation on gene
expression (Table 1). We tested our hypotheses in 476
SARS patients and 449 healthy controls and found that
polymorphism of IFN-γ +874A allele was associated with
susceptibility to SARS in a dose-dependent manner.
Methods
Patient populations
The study was approved by the Clinical Research Ethics
Committee of the Institutional Review Board of the Uni-
versity of Hong Kong/Hospital Authority Hong Kong
West Cluster and included 476 Chinese patients with
SARS (201 male, mean age = 39.8 ± 15.2) and 449 ethni-
cally matched healthy controls from Red Cross (273 male,
mean age = 29.1 ± 10.4). At least 95% of the patients were
documented with SARS-CoV antibody seroconversion
and/or detectable SARS-CoV RNA in respiratory secretions
by RT-PCR.
Genotyping
IFN-γ +874A/T, IL-10 -1082G/A and -592A/C were geno-
typed by TaqMan system (Applied Biosystems, Foster
City, CA, USA) as described previously [20]. TNF-α -308
G/A was also genotyped by TaqMan system with same
condition. The sequences of the primers were 5'-CCT GGT
CCC CAA AAG AAA TG-3' and 5'-TCT TCT GGG CCA CTG
ACT GA-3' and the probes were 6-FAM-TTG AGG GGC
ATG GGG ACG G-TAMRA and VIC-TTG AGG GGC ATG
AGG ACG GG-TAMRA.
Statistical analysis
The frequencies of genotypes and alleles of the 4 single
nucleotide polymorphisms (SNPs) were compared
between the SARS patients and healthy controls by 3 × 2
and 2 × 2 chi square test respectively. In case of signifi-
cance, logistic regression was used for calculating OR with
95% CI and corresponding P-values between groups by
controlling age and sex as covariables. The genotypes of
all SNPs were tested for Hardy-Weinberg equilibrium
(HWE) by chi square test.
Results and discussion
Our case-control study genotyped the 4 SNPs IFN-γ
+874A/T, TNF-α -308G/A, IL-10 -1082G/A and -592A/C
in 476 Chinese patients with SARS and 449 healthy con-
trols. The genotype distributions and allele frequencies of
these 4 SNPs were shown in Table 2. The IFN-γ +874A
allele was overrepresented in SARS patients (83.1%) when
compared with the controls (66.3%) (P < 0.001). It was
also significantly associated with susceptibility to SARS in
a dose-dependent manner (P < 0.001), i.e. individuals
with IFN-γ +874 AA and AT genotype had an odds ratio
(OR) of 5.19 (95% CI, 2.78-9.68) and 2.57 (95% CI,
1.35-4.88) in developing SARS respectively. However, no
significant correlation was observed in SNPs of IL-10 and
TNF-α. All SNPs were in Hardy-Weinberg equilibrium
(HWE) (P > 0.05) in SARS patients and controls by chi
square test, except IL-10-592A/C.
IFN-γ +874A allele has been previously reported to be
associated with infectious diseases such as tuberculosis,
hepatitis B virus infection, and parvovirus infection [20-
22], revealing its potential role of function in host defense
against microbial infections. The mechanism by which
the IFN-γ +874A/T allele influences the susceptibility to
Table 1: Polymorphisms of the genes genotyped
Genes SNPs rs number References
IFN-γ IFN-γ +874 A/T rs2430561 [23]
IL-10 IL-10 -1082 A/G rs1800896 [23,26-27]
IL-10 -592 A/C rs1800872
TNF-α TNF-α -308G/A rs1800629 [28]Page 2 of 4
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production. The T allele of IFN-γ +874A/T provides a
binding site for the transcription factor nuclear factor-κB
(NF-κB), which is able to regulate IFN-γ expression [23].
It is possible that low IFN-γ production may impair their
anti-viral response against SARS-CoV, rendering these
individuals more susceptible to this virus infection. Our
observation that IFN-γ +874A allele was significantly asso-
ciated with SARS-CoV infection suggests a genetic risk fac-
tor for SARS. The role of IFN-γ in antiviral response against
SARS-CoV has also been supported by recent studies
showing that IFN-γ can inhibit the replication of SARS-
CoV in combination with IFN-β in vitro [24,25].
IL-10 and TNF-α SNPs were also included in this study.
They were chosen due to their potential regulation on pro-
tein expression level [26-28]. However, our present data
did not show any significant association of these SNPs
with SARS (Table 2). Nevertheless, we cannot exclude the
role of IL-10 and TNF-α as the susceptibility genes for
SARS, because other SNPs in these 2 genes may also be
involved in gene expression regulation. Further associa-
tion studies on other SNPs, which could alter the gene
expression level are required to ascertain the relationship
of IL-10 and TNF-α in SARS.
We have also compared the genotype and allele frequen-
cies of all the polymorphisms between the death group
and survival group of the SARS patients (Table 3). How-
ever, no significant association was established.
Conclusion
We demonstrated that IFN-γ +874A allele was signifi-
cantly associated with SARS susceptibility in a dose
dependent manner. Due to its role in regulating IFN-γ
expression [15], this allele may be involved in the patho-
genesis of SARS by altering the IFN-γ production.
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Table 3: Genotype frequencies among survival and death SARS 
cases




A/A 41 (71.9) 289 (69.6)
A/T 13 (22.8) 112 (27.0)
T/T 3 (5.3) 14 (3.4)
IL-10-1082 NS
A/A 52 (91.2) 383 (92.3)
A/G 4 (7.0) 31 (7.5)
G/G 1 (1.8) 1 (0.2)
IL-10-592 NS
A/A 28 (49.1) 214 (51.6)
A/C 21 (36.8) 165 (39.8)
C/C 8 (14.0) 36 (8.7)
TNF-a-308 NS
GG 46 (80.7) 353 (85.1)
GA 11 (19.3) 59 (14.2)
AA 0 (0) 3 (0.7)
NS = not significant.










A/A 332 (69.8) 203 (45.2) 5.19 (2.78 – 9.68)
A/T 127 (26.7) 189 (42.1) 2.57 (1.35 – 4.88)
T/T 17 (3.6) 57 (12.7) Reference
IL-10 -1082 NS
A/A 439 (92.2) 411 (91.5) ..
A/G 35 (7.4) 38 (8.5) ..
G/G 2 (0.4) 0 (0) ..
IL-10 -592 NS
A/A 244 (51.3) 209 (46.6) ..
A/C 188 (39.5) 214 (47.7) ..
C/C 44 (9.2) 26 (5.8) ..
TNF-a -308 NS
GG 403 (84.7) 377 (83.9) ..
GA 70 (14.7) 70 (15.6) ..
AA 3 (0.6) 2 (0.5) ..
Allele
IFN-γ +874 <0.001
A 791 (83.1) 595 (66.3) 2.23 (1.75 – 2.83)
T 161 (16.9) 303 (33.7)
IL-10 -1082 NS
A 913 (95.9) 860 (95.8) ..
G 39 (4.1) 38 (4.2) ..
IL-10 -592 NS
A 676 (71.0) 632 (70.4) ..
C 276 (29.0) 266 (29.6) ..
TNF-a -308 NS
G 876 (92.0) 824 (91.8) ..
A 76 (8.0) 74 (8.2) ..
NS = not significant.
*P-value and OR (95% CI) were calculated with the use of logistic 
regression models, adjusted with sex and age.Page 3 of 4
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